Comparing the quality of life in insulin recipient and refusal patients with type 2 diabetes

Mitra Khalili, Fakhri Sabouhi, Parvane Abazari, Ashraf Aminorroaya



Background: Better control of blood sugar and reduction of diabetes complications through insulin therapy could convince people to choose this method. However, patients might refuse insulin therapy due to its painful injection, limitations in daily activities, and hypoglycemia. Thus, insulin therapy could have both positive and negative effects on patients’ quality of life (QOL). Therefore, the aim of this study was to compare the QOL of insulin recipient and insulin refusal patients with type 2 diabetes.

Materials and Methods: This study was a descriptive and comparative research conducted on 126 patients; 63 were insulin recipients and 63 had refused insulin therapy. Participants were under the care of the Endocrine and Metabolism Research Center of Isfahan, Iran. Data were gathered using the Diabetes Quality of Life (DQOL) questionnaire. In this tool, higher scores indicated lower QOL in patients. Data were analyzed using independent t-test, analysis of covariance, Mann–Whitney, Chi-square, and Pearson and Spearman’s correlation.

Results: There was a significant difference (P < 0.001) between insulin recipient patients (mean = 2.02, SD = 0.31) and insulin refusal patients (mean = 1.74, SD = 0.41) in terms of mean QOL score. In addition, men and participants with higher educational levels reported a better QOL (P < 0.001).

Conclusions: Results showed that insulin refusal patients had a better QOL. It seems that QOL is associated with the acceptance or refusal of insulin therapy. Therefore, enhancement of QOL could be related to all aspects of the disease, especially its treatment method and solving the therapeutic problems.

Key words: Insulin therapy, Iran, quality of life, quality of life in type 2 diabetes, type 2 diabetes mellitus


Insulin therapy; Iran; quality of life; quality of life in type 2 diabetes; type 2 diabetes mellitus

Full Text:



Black JM, Hawks JH. Medical‑Surgical Nursing‑Clinical Management for Positive Outcomes. 8th ed. London: Saunders; 2009. p. 1062.

Monjamed Z, Ali Asgharpour M, Mehran A, Peymani T. Quality of life in diabetic. Patients with chronic complications. Hayat J 2006;12:55‑66.

Rakhshandehroo S, Ghaffari M, Heidarnia A, Rajab A. The effectiveness of the intervention on metabolic control in diabetic patients referred to Iranian Diabetes Society. Iran J Diabetes Lipid Disord 2009;9:57‑64.

Habibi R, Sultan M, HabibiGh. Factors affecting the rejection of insulin therapy in diabetic patients. Iran J Diabetes Lipid Disord 2012;11:366‑76.

Kuznetsov L, Griffin SJ, Davies MJ, Lauritzen T, Khunti K, Rutten GE, et al. Diabetes‑specific quality of life but not health status is independently associated with glycaemic control among patients with type 2 diabetes: A cross‑sectional analysis of the ADDITION‑Europe trial cohort. Diabetes Res Clin Pract 2014;104:281‑7.

Ioannidis G, Gordon M, Adachi JD. Quality of life in osteoporosis. Nurs Clin North Am 2001;36:481‑9, ix.

Khaledi Sh, Moridi G, Gharibi F. Evaluation of the eight dimensions of quality of life in patients with diabetes type two diabetes center in Sanandaj in 2009. J Fasa Univ Med Sci 2011;1:29‑37.

Fal AM, Jankowska B, Uchmanowicz I, Sen M, Panaszek B, Polanski J. Type 2 diabetes quality of life patients treated with insulin and oral hypoglycemic medication. Acta Diabetol 2011;48:237‑42.

Vadstrup ES, Frølich A, Perrild H, Borg E, Røder M. Health‑related quality of life and self‑related health in patients with type 2 diabetes: Effects of group‑based rehabilitation versus individual

counselling. Health Qual Life Outcomes 2011;9:110.

Pellico LH. Focus on adult health: Medical‑surgical nursing, Philadelphia: Lippincott Williams and Wilkins; 2013. p. 816‑9.

Heine RJ, Diamant M, Mbanya JC, Nathan DM. Management of hyperglycaemia in type 2 diabetes: The end of recurrent failure. BMJ 2006;333:1200‑4.

Chen CC, Chang MP, Hsieh MH, Huang CY, Liao LN, Li TC. Evaluation of perception of insulin therapy among Chinese patients with type 2 diabetes mellitus. Diabetes Metab 2011;37:389‑94.

Ghanbari A, Kazemnejad E. Assessing quality of life in patients with non‑insulin dependent diabetic patients and healthy individuals Razi Hospital Diabetes Education Center. Modares J Med Sci 2004;7,1:69‑80.

Bradley C, Gilbride CJ. Improving treatment satisfaction and other patient‑reported outcomes in people with type 2 diabetes: The role of once‑daily insulin glargine. Diabetes Obes Metab 2008;10(Suppl 2):50‑65.

Alizad Jahani S, Majdzadeh R, Ghorbani M, Khosravi S, Bajauri A, Amini Sh, et al. Factors influencing the unwillingness of diabetic patients on insulin therapy in patients with diabetes centers in1389‑1390: A qualitative study. Iran J Diabetes Lipid Disord 2011;10,5:520‑7.

Davis SN, Renda SM. Psychological insulin resistance: Overcoming barriers to starting insulin therapy. Dibetes Educ 2006:32(Suppl 4):146‑52S.

Podbielska H, Madziarska K, Demczuk‑Włodarczyk E. Quality of life of people suffering from the diabetes type 2‑examination of the influence of various factors to prevent complications. EPMA J 2014;5(Suppl 1):A72.

American Diabetes Association. Standards of medical care in diabetes‑‑2014. Diabetes Care 2014;37(Suppl 1):S14‑80.

Masaeli N, Attari A, Molavi H, Najafi M, Siavash M. Normative data and psychometric properties of the quality of life questionnaire for patients with diabetes mellitus. Koomesh 2010;11:263‑9.

Shim YT, Lee J, Toh MP, Tang WE, Ko Y. Health‑related quality of life and glycaemic control in patients with type 2 diabetes mellitus in Singapore. Diabet Med 2012;29:e241‑8.

Sadeghi Ahari S, Arshi S, Iran Parvar M, Amani F, Seiah Posh H. The effect of complications of diabetes Type II on the quality of life in diabetic patients. J Ardebil Univ med Sci 2008;8:394‑402.

Mohammadpour Y, Haririan H, Moghaddasian S, Ebrahimi H. The quality of lifein diabetic patients attending the Diabetes Center, Tabriz University of Medical Sciences in 1386. J Urmia Nurs Midwifery Fac 2007;6,1:26‑37.

Alavi M, Ghofranipour F, Ahmadi F, Rajab A, Babaei Rouchee G. The quality of life in patients with diabetes mellitus referred to Iranian Diabetes Society. Behbood J 2004;8,2:47‑51.

Baghiani Moghadam M, Afkhami Ardakani M, Mazloomi SS, Saeedi Zade M. The Study of life quality of diabetes type II parients in Yazd. J Shaheed Sadoughi Univ Med Sci 2006;4:49‑54.

Nejat S. Quality of life and its measurement. Iran J Epidemiol 2008;4,2:57‑62.

Braun A, Sämann A, Kubiak T, Zieschang T, Kloos C, Müller UA, et al. Effects of metabolic control, patient education and initiation of insulin therapy on the quality of life of patients with type 2 diabetes mellitus. Patient Educ Couns 2008;73:50‑9.

Papathanasiou A, Shea S, Koutsovasilis A, Melidonis A, Papavasiliou E, Lionis C. Reporting distress and quality of life of patients with diabetes mellitus in primary and secondary care in Greece. Ment Health Fam Med 2008;5:85‑93.

Shaban M, Monjamed Z, Abbas M, Hassanpour Dehkordi A. Relationship between cancer characteristics and quality of life in cancer pations receiving chemotherapy. Haiat 2004;10,22:79‑84.

Peymani M, Monjemed Z, Asghar Poor A, Mehran A. Comparison of quality of life in diabetic patients with cardiovascular complications referring to selected endocrine Clinics of Tehran University of Medical Sciences in 2004‑2005. J Med Counc IR Iran 2007;25,2:142‑8.

Yaghoobi M, Taheri N, Saeb AR, Shirzaie K, Kazemi S. Study quality of life in diabetic patients referring to Mashhad Parsian Clinic (Summer 2009). Modern Care J 2011;7:15‑21.

Tang WL, Wang YM, Du WM, Cheng NN, Chen BY. Assessment of quality of life and relevant factors in elderly diabetic patients in Shanghai community. Pharmacoepidemiol Drug Saf 2006;15:123‑30.


  • There are currently no refbacks.